238 related articles for article (PubMed ID: 24493968)
1. Targeting cancer using cholesterol conjugates.
Radwan AA; Alanazi FK
Saudi Pharm J; 2014 Jan; 22(1):3-16. PubMed ID: 24493968
[TBL] [Abstract][Full Text] [Related]
2. siRNA conjugate delivery systems.
Jeong JH; Mok H; Oh YK; Park TG
Bioconjug Chem; 2009 Jan; 20(1):5-14. PubMed ID: 19053311
[TBL] [Abstract][Full Text] [Related]
3. Selective Delivery of Clinically Approved Tubulin Binding Agents through Covalent Conjugation to an Active Targeting Moiety.
Collyer SE; Stack GD; Walsh JJ
Curr Med Chem; 2022 Aug; 29(31):5179-5211. PubMed ID: 35366763
[TBL] [Abstract][Full Text] [Related]
4. Mitochondrial-Targeting Anticancer Agent Conjugates and Nanocarrier Systems for Cancer Treatment.
Battogtokh G; Cho YY; Lee JY; Lee HS; Kang HC
Front Pharmacol; 2018; 9():922. PubMed ID: 30174604
[TBL] [Abstract][Full Text] [Related]
5. Cellular delivery of dinucleotides by conjugation with small molecules: targeting translation initiation for anticancer applications.
Kleczewska N; Sikorski PJ; Warminska Z; Markiewicz L; Kasprzyk R; Baran N; Kwapiszewska K; Karpinska A; Michalski J; Holyst R; Kowalska J; Jemielity J
Chem Sci; 2021 Aug; 12(30):10242-10251. PubMed ID: 34377411
[TBL] [Abstract][Full Text] [Related]
6. Transferrin receptor-mediated endocytosis: a useful target for cancer therapy.
Tortorella S; Karagiannis TC
J Membr Biol; 2014 Apr; 247(4):291-307. PubMed ID: 24573305
[TBL] [Abstract][Full Text] [Related]
7. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
Ojima I
Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
[TBL] [Abstract][Full Text] [Related]
8. Enhancing the anticancer efficacy of camptothecin using biotinylated poly(ethylene glycol) conjugates in sensitive and multidrug-resistant human ovarian carcinoma cells.
Minko T; Paranjpe PV; Qiu B; Lalloo A; Won R; Stein S; Sinko PJ
Cancer Chemother Pharmacol; 2002 Aug; 50(2):143-50. PubMed ID: 12172980
[TBL] [Abstract][Full Text] [Related]
9. Conjugates of Tetrapyrrolic Macrocycles as Potential Anticancer Target-Oriented Photosensitizers.
Korolchuk AM; Zolottsev VA; Misharin AY
Top Curr Chem (Cham); 2023 Feb; 381(2):10. PubMed ID: 36826755
[TBL] [Abstract][Full Text] [Related]
10. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
[TBL] [Abstract][Full Text] [Related]
11. Design and encapsulation of anticancer dual HSP27 and HER2 inhibitor into low density lipoprotein to target ovarian cancer cells.
Alhadad LJ; Harisa GI; Alanazi FK
Saudi Pharm J; 2020 Apr; 28(4):387-396. PubMed ID: 32273796
[TBL] [Abstract][Full Text] [Related]
12. New Salicylanilide Derivatives and Their Peptide Conjugates as Anticancer Compounds: Synthesis, Characterization, and
Horváth L; Biri-Kovács B; Baranyai Z; Stipsicz B; Méhes E; Jezsó B; Krátký M; Vinšová J; Bősze S
ACS Omega; 2024 Apr; 9(15):16927-16948. PubMed ID: 38645331
[TBL] [Abstract][Full Text] [Related]
13. The Synthesis of Conjugated Peptides Containing Triazole and Quinolone-3-Carboxamide Moieties Designed as Anticancer Agents.
Esfandiari Mazandaran K; Baharloui M; Houshdar Tehrani MH; Mirshokraee SA; Balalaie S
Iran J Biotechnol; 2021 Oct; 19(4):e2917. PubMed ID: 35350640
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and Evaluation of Novel Erlotinib-NSAID Conjugates as More Comprehensive Anticancer Agents.
Zhang Y; Tortorella MD; Liao J; Qin X; Chen T; Luo J; Guan J; Talley JJ; Tu Z
ACS Med Chem Lett; 2015 Oct; 6(10):1086-90. PubMed ID: 26487917
[TBL] [Abstract][Full Text] [Related]
15. Aspergillus nidulans thermostable arginine deiminase-Dextran conjugates with enhanced molecular stability, proteolytic resistance, pharmacokinetic properties and anticancer activity.
El-Sayed ASA; Shindia AA; Zeid AAA; Yassin AM; Sitohy MZ; Sitohy B
Enzyme Microb Technol; 2019 Dec; 131():109432. PubMed ID: 31615671
[TBL] [Abstract][Full Text] [Related]
16. Polypeptides-Drug Conjugates for Anticancer Therapy.
Zhang Y; He P; Zhang P; Yi X; Xiao C; Chen X
Adv Healthc Mater; 2021 Jun; 10(11):e2001974. PubMed ID: 33929786
[TBL] [Abstract][Full Text] [Related]
17. Synthesis, Anticancer, and Antibacterial Activity of Betulinic and Betulonic Acid C-28-Triphenylphosphonium Conjugates with Variable Alkyl Linker Length.
Tsepaeva OV; Nemtarev AV; Salikhova TI; Abdullin TI; Grigor Eva LR; Khozyainova SA; Mironov VF
Anticancer Agents Med Chem; 2020; 20(3):286-300. PubMed ID: 31660842
[TBL] [Abstract][Full Text] [Related]
18. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
Pérez-Herrero E; Fernández-Medarde A
Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
[TBL] [Abstract][Full Text] [Related]
19. Synthesis, Characterization, Cellular Uptake, and
Xu B; Yuan L; Hu Y; Xu Z; Qin JJ; Cheng XD
Front Pharmacol; 2020; 11():598155. PubMed ID: 33568999
[TBL] [Abstract][Full Text] [Related]
20. A Novel Dextran-Based Dual Drug Conjugate Targeted Tumors with High Biodistribution Ratio of Tumors to Normal Tissues.
Liu J; Zhang N; Wu J; Dong P; Lv H; Wang Q; Wang S; Yang H; Wang S; Li X; Hu J; Wang A; Li DJ; Shi Y
Int J Nanomedicine; 2022; 17():4895-4910. PubMed ID: 36262192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
